MedTrace Logo

Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation

NCT02087657 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-02-14

No results posted yet for this study

Summary

By doing this study, researchers hope to learn the following:

* The safety of hyperbaric oxygen administration in the setting of the autologous transplant
* The effects of hyperbaric oxygen administration on neutrophil count recovery and engraftment

Conditions

Interventions

DEVICE

Administration of hyperbaric oxygen

Hyperbaric oxygen at 2.5 atmospheres absolute (ATA) for a total of 2 hours

Sponsors & Collaborators

  • SWOG Cancer Research Network

    collaborator NETWORK

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Omar Aljitawi, MD · University of Kansas Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02087657 on ClinicalTrials.gov